Modafinil, first developed to treat narcolepsy, has become widely recognized as a cognitive enhancer and earned the nickname “smart drug” or nootropic. Its ability to boost focus, alertness, and mental performance has sparked curiosity about what sets it apart. By understanding its mechanisms and benefits, it’s easier to see why Modafinil has gained its reputation…

Modafinil, originally developed to treat narcolepsy, has gained a reputation as a cognitive enhancer, with students, professionals, and academics turning to it for a productivity and focus boost. But what is the experience of taking Modafinil really like? From heightened alertness and concentration to potential downsides, understanding its effects sheds light on why it’s often…

Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), leaves many people grappling with symptoms like fatigue, brain fog, and neurocognitive challenges long after recovering from the acute phase of the virus. These lingering effects can disrupt daily life for weeks or even months, making the search for effective treatments a pressing need. Modafinil, originally…

Excessive daytime sleepiness (EDS) can leave individuals feeling persistently drowsy and struggling to stay alert, even after a full night’s rest. This condition can significantly impair daily functioning, productivity, and safety. Modafinil, a wakefulness-promoting agent, has become a widely used treatment for EDS associated with disorders such as narcolepsy, obstructive sleep apnea (OSA), and shift…

Modafinil and its related compound, Armodafinil, are wakefulness-promoting medications prescribed for conditions such as narcolepsy, shift work sleep disorder, and obstructive sleep apnea. While they are known for improving alertness and cognitive function, unsupervised use raises concerns about potential side effects. Recent cases in Singapore have highlighted possible links between Modafinil and conditions like conjunctivitis…

Multiple Sclerosis (MS) is a chronic neurological disorder affecting the central nervous system, often causing symptoms like muscle weakness, coordination issues, and cognitive difficulties. Fatigue, one of the most common and disabling symptoms, impacts up to 80% of MS patients, severely affecting daily life and overall well-being. Modafinil, a wake-promoting agent, has been explored as…

Understanding Post-Stroke Fatigue Post-stroke fatigue is a common condition that affects between 60-70% of stroke survivors shortly after the event. Approximately 40% of these individuals experience persistent fatigue for months or even years. This fatigue significantly impacts their ability to perform daily activities, participate in social interactions, and overall quality of life. Why This Study…

Sunosi (solriamfetol) and Modafinil are both FDA-approved medications used to treat excessive daytime sleepiness (EDS) associated with narcolepsy and obstructive sleep apnea (OSA). While they share a goal—to improve wakefulness—their mechanisms of action, clinical effectiveness, side effect profiles, and cost structures differ in ways that may influence treatment decisions. Key Takeaways What Is Sunosi (Solriamfetol)?…